Checkpoint inhibitor and immuno-oncology... (01:07:32)
While there is great interest in the scientific community to...
|
How to accelerate your clinical reporting... (50:45)
As the demand for personalized cancer treatment grows, clinical...
|
Expert panel: Mitigating variability in somatic... (01:00:23)
Next-generation sequencing (NGS) oncology panels are becoming...
|
Clinician’s Roundtable: Interpreting genomic... (01:31:50)
You’re invited to attend the 2024 Clinician’s Roundtable, a virtual...
|
Using COSMIC to predict, identify, and avoid... (01:07:25)
Whether your lab is researching and developing targeted cancer...
|
How clinical labs can confidently assess... (45:33)
Across various stages of the clinical oncology workflow, from panel...
|
How to scale-up comprehensive genomic profiling... (01:00:00)
As gene panels increase in size, comprehensive genomic profiling...
|
Circulating Tumor Cell Detection and Analysis... (43:23)
Circulating tumor cells (CTCs) are cells that leave the primary...
|
Real-World Applications of Clinical Metagenomic... (01:00:48)
Clinical metagenomic next-generation sequencing (mNGS), the...
|
Indication Expansion and Repurposing of PIK3CA... (24:12)
|
Scale your comprehensive genomic profiling... (52:17)
Automating and scaling a comprehensive genomic profiling workflow...
|
2023 Clinical Oncology Summit: Part 2 - NA (01:24:33)
How to improve your existing pipeline for somatic mutation...
|
